Monitor gait and tremor remotely
- Trial ID
- NCT06573762
- Official Title
- Remote Monitoring Using Commercially Available Activity Trackers and Computer Vision Provides a Holistic, Low-cost Assessment of Parkinson's Disease Symptoms
- Goal
- Monitor gait and tremor remotely
- Status
- RECRUITING
- Sponsor
- Jacob E. Simmering
- Study Type
- OBSERVATIONAL
- Enrollment
- 120 participants
- Conditions
- Parkinson Disease
Plain-Language Summary
The goal is to see if consumer activity trackers plus computer vision can give a holistic, low-cost picture of Parkinson's motor symptoms over time, capturing real-world changes that clinic visits often miss. Participants wear a Fitbit that records steps, activity, sleep and heart rate, and submit short videos that are analyzed by computer vision to quantify tremor, slowness, and gait; combining these objective measures could make symptom tracking more continuous and precise. There is no drug or device treatment here, the study only collects data remotely to evaluate how well these tools reflect Parkinson's signs. They are enrolling people aged 50 to 110 in two groups, either newly referred with possible Parkinson's who have not been previously diagnosed, or clinic patients diagnosed within the past 6 months; exclusions include being bed- or wheelchair-bound, non-English speakers, prisoners, inability to consent, or not having a phone that supports the Fitbit app.
Locations
- University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to see if consumer activity trackers plus computer vision can give a holistic, low-cost picture of Parkinson's motor symptoms over time, capturing real-world changes that clinic visits often miss. Participants wear a Fitbit that records steps, activity, sleep and heart rate, and submit short videos that are analyzed by computer vision to quantify tremor, slowness, and gait; combining these objective measures could make symptom tracking more continuous and precise. There is no drug or device treatment here, the study only collects data remotely to evaluate how well these tools reflect Parkinson's signs. They are enrolling people aged 50 to 110 in two groups, either newly referred with possible Parkinson's who have not been previously diagnosed, or clinic patients diagnosed within the past 6 months; exclusions include being bed- or wheelchair-bound, non-English speakers, prisoners, inability to consent, or not having a phone that supports the Fitbit app.
- Who can participate?
- Participants must be between 50 Years and 110 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 9 months.